| Schedule of Reportable Segment Product Sales, Net and Net Loss |
The Company's reportable segment product sales, net and net loss for the three and nine months ended September 30, 2025 and 2024 consisted of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended September 30, |
|
|
Nine months ended September 30, |
|
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
Product sales, net |
|
$ |
3,256 |
|
|
$ |
3,865 |
|
|
$ |
10,482 |
|
|
$ |
11,821 |
|
Cost of goods sold |
|
|
1,677 |
|
|
|
2,087 |
|
|
|
5,401 |
|
|
|
6,330 |
|
Gross profit |
|
|
1,579 |
|
|
|
1,778 |
|
|
|
5,081 |
|
|
|
5,491 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Research and development expense |
|
|
24 |
|
|
|
29 |
|
|
|
104 |
|
|
|
93 |
|
Sales expense |
|
|
691 |
|
|
|
820 |
|
|
|
2,140 |
|
|
|
2,426 |
|
Marketing expense |
|
|
429 |
|
|
|
530 |
|
|
|
1,248 |
|
|
|
1,526 |
|
General and administrative expense |
|
|
710 |
|
|
|
740 |
|
|
|
2,506 |
|
|
|
2,990 |
|
Benefit from reversal of accrued payroll taxes |
|
|
— |
|
|
|
— |
|
|
|
(522 |
) |
|
|
— |
|
Total operating expenses |
|
|
1,854 |
|
|
|
2,119 |
|
|
|
5,476 |
|
|
|
7,035 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating loss |
|
|
(275 |
) |
|
|
(341 |
) |
|
|
(395 |
) |
|
|
(1,544 |
) |
Gain on extinguishment of debt |
|
|
— |
|
|
|
— |
|
|
|
(38 |
) |
|
|
— |
|
Other expense, net |
|
|
107 |
|
|
|
115 |
|
|
|
388 |
|
|
|
118 |
|
Loss before income taxes |
|
|
(382 |
) |
|
|
(456 |
) |
|
|
(745 |
) |
|
|
(1,662 |
) |
Income tax expense |
|
|
— |
|
|
|
— |
|
|
|
7 |
|
|
|
6 |
|
Net loss |
|
$ |
(382 |
) |
|
$ |
(456 |
) |
|
$ |
(752 |
) |
|
$ |
(1,668 |
) |
|